Literature DB >> 186788

beta-Endorphin: cross tolerance to and cross physical dependence on morphine.

L F Tseng, H H Loh, C H Li.   

Abstract

The effects of beta-endorphin on the antinociceptive responses and abrupt withdrawal jumping in morphine-dependent mice were studied. Mice were rendered morphine dependent by implantation of a morphine pellet (75 mg base) for 3 days. The analgesic response to beta-endorphin decreased after morphine pellet implantation, as evidenced by an eight-fold increase in the median antinociceptive dose of morphine was found. In small doses (0.09-0.17 mug per mouse), beta-endorphin suppressed abrupt withdrawal jumping. Met-enkephalin, even in high doses (200 mug per mouse), did not suppress abrupt withdrawal jumping.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 186788      PMCID: PMC431379          DOI: 10.1073/pnas.73.11.4187

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  10 in total

1.  SOME NARCOTIC ANTAGONISTS IN THE BENZOMORPHAN SERIES.

Authors:  L S HARRIS; A K PIERSON
Journal:  J Pharmacol Exp Ther       Date:  1964-02       Impact factor: 4.030

2.  Pharmacological effects produced by intracerebral injection of drugs in the conscious mouse.

Authors:  T J HALEY; W G MCCORMICK
Journal:  Br J Pharmacol Chemother       Date:  1957-03

3.  Opioid activity of a peptide, beta-lipotropin-(61-91), derived from beta-lipotropin.

Authors:  B M Cox; A Goldstein; C H Hi
Journal:  Proc Natl Acad Sci U S A       Date:  1976-06       Impact factor: 11.205

4.  Isolation and structure of an untriakontapeptide with opiate activity from camel pituitary glands.

Authors:  C H Li; D Chung
Journal:  Proc Natl Acad Sci U S A       Date:  1976-04       Impact factor: 11.205

5.  C fragment of lipotropin has a high affinity for brain opiate receptors.

Authors:  N J Birdsall; E C Hulme
Journal:  Nature       Date:  1976-04-29       Impact factor: 49.962

6.  Analgesia induced in vivo by central administration of enkephalin in rat.

Authors:  J D Belluzzi; N Grant; V Garsky; D Sarantakis; C D Wise; L Stein
Journal:  Nature       Date:  1976-04-15       Impact factor: 49.962

7.  beta-endorphin is a potent analgesic agent.

Authors:  H H Loh; L F Tseng; E Wei; C H Li
Journal:  Proc Natl Acad Sci U S A       Date:  1976-08       Impact factor: 11.205

8.  New hot plate tests to quantify antinociceptive and narcotic antagonist activities.

Authors:  S I Ankier
Journal:  Eur J Pharmacol       Date:  1974-06       Impact factor: 4.432

9.  Formulation of a morphine implantation pellet suitable for tolerance-physical dependence studies in mice.

Authors:  R D Gibson; J E Tingstad
Journal:  J Pharm Sci       Date:  1970-03       Impact factor: 3.534

10.  Simultaneous quantitative assessment of morphine tolerance and physical dependence.

Authors:  E L Way; H H Loh; F H Shen
Journal:  J Pharmacol Exp Ther       Date:  1969-05       Impact factor: 4.030

  10 in total
  5 in total

1.  beta-Endorphin: development of tolerance and its reversal by 5-hydroxytryptophan in cats.

Authors:  Y Hosobuchi; M Meglio; J E Adams; C H Li
Journal:  Proc Natl Acad Sci U S A       Date:  1977-09       Impact factor: 11.205

2.  Appearance of beta-endorphin-like immunoreactivity in human ventricular cerebrospinal fluid upon analgesic electrical stimulation.

Authors:  H Akil; D E Richardson; J D Barchas; C H Li
Journal:  Proc Natl Acad Sci U S A       Date:  1978-10       Impact factor: 11.205

3.  Biphasic effects of chronic saccharin intake on pain responses of healthy and diabetic rats of two genetically selected strains.

Authors:  F Bergmann; E Cohen; I Lieblich
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

Review 4.  Are astroglial cells involved in morphine tolerance?

Authors:  L Rönnbäck; E Hansson
Journal:  Neurochem Res       Date:  1988-02       Impact factor: 3.996

5.  D-ala2-methionine-enkephalinamide self-administration in the morphine-dependent rat.

Authors:  F C Tortella; J E Moreton
Journal:  Psychopharmacology (Berl)       Date:  1980       Impact factor: 4.530

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.